Archive - January 2022
CDI prevention reaches date with destiny
Poolbeg Pharma dives into nasally administered antivirals
Omicron: Viral Load Can Be At Its Highest At Day Five So Cutting Isolation Period Doesn’t Make Sense
FDA Approves Ryaltris (mometasone and olopatadine) Nasal Spray for Seasonal Allergic Rhinitis
Gates Foundation supports HIV and malaria research
While Omicron continues to dominate across the world, COVID-19 travel requirements remain
Vir Biotech launches new research programme for HIV and malaria prevention
BioNTech and InstaDeep collaboration develops SARS-CoV-2 Early Warning System